To regenerate organs, we must 1st decode how they heal. Mammals have repaired tissues for millions of years, yet the instruction manual for organ-scale coordination remained a mystery.
📢We constructed OWHA, a 4D multimodal healing atlas to study this!📢
#SyntheticRegeneration
📢 Authors provide an overview of the applications, molecular mechanisms, and translational potential of #HaCaT cells in the exploration of #WoundHealing.
Read the review👉 https://t.co/jykPud1dSb
Out today!
An AI model infers spatial proteomic patterns at the single-cell level from routine H&E slides to predict molecular biomarkers, prognosis and immunotherapy response
https://t.co/WKFZWefYPd
Using spatial transcriptomics to train AI to analyze routine H&E slides.
Together with Celso Camilo's group, we just published a new paper introducing MOSAIC, a computer vision method that predicts gene expression from histology and uses those predictions to infer cell identity.
The key idea was to look beyond each cell’s individual morphology and incorporate its neighbors, using the surrounding cellular context to guide the prediction.
Paper here: https://t.co/ge0eMbL0mZ
It was such a delight to share our latest work in #SyntheticRegeneration! Really excited about all of the remarkable discoveries being made at @ColumbiaPS!
Single-cell analysis of 14,685 cells revealed T-cell infiltration into aging brain stem-cell niches. These T cells produced interferon-gamma, which suppressed neural stem-cell proliferation. Immune cells can directly interfere with brain regeneration.
https://t.co/7gNAw4ywlL
1/ 🔥New study: Most perturbation models answer “if I knock out gene X, what happens?” We asked inverse: given a disease state, what drove them? 🔄
ExPert traces patient cells to their cause: hidden liver-disease biology, mitochondrial defects from blood https://t.co/5VpdE21nSi
CellWhisperer uses multimodal learning of transcriptomes and text to answer questions about single-cell RNA-sequencing data https://t.co/bLy1lvB68X
https://t.co/OHTQjiGehY
Motherhood’s Sentinels: Pregnancy Induces Tissue-Resident Memory T Cells to Curb Breast Cancer Growth—this In the Spotlight commentary highlights a recent Nature Immunology article. https://t.co/vwdjEGJozl #CD8TCells#TCells#TissueResidentImmunity#BreastCancer
Tissue-resident macrophages sense colonic stiffening via Piezo1, releasing NGF to sensitize TRPV1+ nociceptors for visceral pain @SciImmunology
https://t.co/gr8sVwEtxQ 🇨🇳
Two VIPerturb-seq updates:
1. Updated preprint w/@CalebLareau where we enrich for VIPs using RNA markers before sequencing: https://t.co/jlEqFxzAo7
2. Delighted to share that @10xGenomics is releasing a commercial VIPerturb-seq product! Check it out at https://t.co/VLimEl7BZL
Ever wondered what a cell has experienced in the past? This is in general hard to measure. Here we introduce the recordanelle, to equip cells with a tool that lets them record their own history.
https://t.co/JVM3yOit8s
@NatureBiotech@ETH@randall_platt@ETH_BSSE
Macrophages wear many hats: from guardians of tissue health to architects of tumor niches and targets for therapy. Explore their remarkable plasticity, from homeostasis to disease and back, in the new @TrendsImmuno special issue.
https://t.co/9sMRxF6Auh
🧬 The M1/M2 macrophage paradigm is no longer sufficient. What comes next?
A new Immunity Perspective by Ginhoux, Mulder, Arcila-Barrera, and Amit proposes a major conceptual shift: Macrophages should be defined by combinations of functional gene programs—not binary polarization states or individual markers.
🔬 1. Macrophage identity is modular
The authors propose eight recurring transcriptional programs:
① Homeostasis: LYVE1, TIMD4, MRC1
② Scavenger/lipid handling: TREM2, APOE, GPNMB, SPP1
③ Fibrosis/remodeling: SPP1, MMP9, TGFB1
④ Immunosuppression: IL10, IDO1, CD274
⑤ Antigen presentation: HLA-DRA, CD74, CIITA
⑥ Interferon response: CXCL9, CXCL10, STAT1
⑦ Inflammation: NLRP3, IL1B, TNF
⑧ Monocyte recruitment/transition: CCR2, FCN1, S100A8
A ninth category accommodates previously unrecognized programs.
Crucially, individual macrophages can activate several programs simultaneously.
🧠 2. The same marker can indicate opposite biological functions
TREM2 illustrates this paradox.
In Alzheimer's disease, TREM2-associated microglial programs may support lipid handling, debris clearance, and tissue protection.
In obesity, related macrophage programs can contribute to metabolic adaptation.
However, in tumors, TREM2/SPP1-associated macrophages may promote immunosuppression, fibrosis, and treatment resistance.
TREM2 expression alone does not define macrophage function.
⚡ 3. Why macrophage-targeted therapies sometimes fail
Clinical experience demonstrates the limitations of single-target approaches.
• CSF1R inhibition has shown activity in tenosynovial giant cell tumors but limited efficacy in glioblastoma.
• Anti-TREM2 antibody PY314 demonstrated minimal antitumor activity in a phase 1a ovarian cancer study.
• Anti-CD47 antibody magrolimab failed to improve survival in phase 3 AML trials.
These outcomes highlight the importance of compensatory immune programs and tissue-specific biology.
💊 4. From macrophage depletion to functional reprogramming
The authors highlight emerging therapeutic strategies:
TREM2-targeted immunocytokines: Combine macrophage targeting with tumor-localized activation of a masked IL-2 superkine.
Armored CAR-T cells: Target suppressive TREM2⁺ or FOLR2⁺ macrophages while restricting IL-12 secretion to the tumor environment.
CAR-macrophages: Engineer macrophages to enhance tumor phagocytosis and remodel local immunity.
In vivo myeloid engineering: Use delivery platforms to introduce therapeutic programs into macrophages.
These approaches aim to modify entire immune ecosystems rather than simply eliminate marker-positive cells.
🔍 5. A new framework for macrophage drug discovery
The proposed therapeutic logic is:
Single-cell profiling → Functional module scoring → Regulatory network identification → Surface-accessible targeting → Spatially restricted reprogramming
This framework could be particularly valuable in cancer, fibrosis, obesity, and neurodegeneration.
However, transcriptional modules remain working classifications, and experimental perturbation is necessary to establish causal functions.
💡 The broader implication
Macrophage plasticity is both a therapeutic challenge and an opportunity.
A macrophage population beneficial during acute tissue repair may become pathogenic when the same program persists chronically.
Future therapies must therefore consider cellular origin, tissue location, disease stage, regulatory state, and treatment timing.
The next frontier in immunotherapy is not simply targeting macrophages—it is programming the right macrophage functions, in the right tissue, at the right time.
📄 Ginhoux F, Mulder K, Arcila-Barrera S, Amit I.
Embracing macrophage complexity for research and translation.
Immunity. 2026. Perspective.
DOI: https://t.co/6jmRrThV1R
#Macrophages #Immunology #Immunotherapy #TREM2 #SPP1 #TumorMicroenvironment #SingleCellRNAseq #CARMacrophages #SyntheticImmunology #CancerResearch #DrugDiscovery